156 related articles for article (PubMed ID: 22218030)
1. Editorial: hepatocellular carcinoma in type 2 diabetes: more than meets the eye.
Baffy G
Am J Gastroenterol; 2012 Jan; 107(1):53-5. PubMed ID: 22218030
[TBL] [Abstract][Full Text] [Related]
2. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
[TBL] [Abstract][Full Text] [Related]
3. Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome.
Kasmari AJ; Welch A; Liu G; Leslie D; McGarrity T; Riley T
Am J Med; 2017 Jun; 130(6):746.e1-746.e7. PubMed ID: 28109969
[TBL] [Abstract][Full Text] [Related]
4. Viral hepatitis and hepatocellular carcinoma.
Marrero CR; Marrero JA
Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and metformin in hepatocellular carcinoma.
Fujita K; Iwama H; Miyoshi H; Tani J; Oura K; Tadokoro T; Sakamoto T; Nomura T; Morishita A; Yoneyama H; Masaki T
World J Gastroenterol; 2016 Jul; 22(27):6100-13. PubMed ID: 27468203
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hepatocellular carcinoma: progress and challenges.
Shire AM; Roberts LR
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):49-64. PubMed ID: 22419004
[TBL] [Abstract][Full Text] [Related]
7. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma, a rapidly increasing public health problem: the Tulane experience 2003-2009.
Tangutur NK; Medvedev SF; Regenstein F; Balart LA
J La State Med Soc; 2011; 163(4):185-90. PubMed ID: 21954650
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.
Pocha C; Kolly P; Dufour JF
Semin Liver Dis; 2015 Aug; 35(3):304-17. PubMed ID: 26378646
[TBL] [Abstract][Full Text] [Related]
10. Diabetes is not an independent risk factor for hepatocellular carcinoma.
Tseng CH
Diabetes Metab Res Rev; 2013 Oct; 29(7):515-24. PubMed ID: 23658071
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of hepatocellular carcinoma: consider the population.
Mittal S; El-Serag HB
J Clin Gastroenterol; 2013 Jul; 47 Suppl(0):S2-6. PubMed ID: 23632345
[TBL] [Abstract][Full Text] [Related]
12. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
[TBL] [Abstract][Full Text] [Related]
13. Screening tests for hepatocellular carcinoma.
Marrero JA
Clin Liver Dis; 2005 May; 9(2):235-51, vi. PubMed ID: 15831271
[TBL] [Abstract][Full Text] [Related]
14. [Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma].
Lengyel G; Fehér J
Orv Hetil; 2010 Jul; 151(29):1177-81. PubMed ID: 20591786
[TBL] [Abstract][Full Text] [Related]
15. [Hepatocellular carcinoma: Increase in incidence or future plague?].
Raoul JL; Raimbourg J; Hiret S; Adhoute X; Senellart H
Bull Cancer; 2018 May; 105(5):502-507. PubMed ID: 29567280
[TBL] [Abstract][Full Text] [Related]
16. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
[TBL] [Abstract][Full Text] [Related]
17. Metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.
Zhang ZJ; Zheng ZJ; Shi R; Su Q; Jiang Q; Kip KE
J Clin Endocrinol Metab; 2012 Jul; 97(7):2347-53. PubMed ID: 22523334
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
Massoud O; Charlton M
Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C.
Hedenstierna M; Nangarhari A; Weiland O; Aleman S
Clin Infect Dis; 2016 Sep; 63(6):723-9. PubMed ID: 27282709
[TBL] [Abstract][Full Text] [Related]
20. Advances in prevention and diagnosis of hepatocellular carcinoma.
Spangenberg HC; Thimme R; Blum HE
Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):425-33. PubMed ID: 19072390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
